Methylphenidate transdermal system: Phase II data

In the double-blind Phase II trial (SPD485.201) in 80 children with ADHD, MTS significantly improved the SKAMP deportment scores for 2-9 hours vs. placebo (p<=0.0001). MTS also met all secondary endpo...